Microbiome Sequencing Services Market by Service (Sample Preparation, Sequencing, Library Preparation), Type (Amplicon Sequencing, Whole Genome Sequencing), Technology (Sequencing by Synthesis, Nanopore Sequencing), End User - Global Forecast to 2028

Abstract
The microbiome sequencing services market is projected to grow from USD 284 million in 2023 to USD 555 million by 2028 at a CAGR of 14.3%. Expanding applications of microbiome sequencing in therapeutics development serves as a key opportunity for the players operating in this market. Microbiome sequencing is expanding its applications beyond research and is increasingly being utilized in therapeutics development, including the study of the skin microbiome and oral microbiome sequencing.

These applications have the potential to advance the understanding of the role of microbiota in health and disease and inform the development of targeted interventions for improving skin health and oral health.

“Sequencing and library preparation segment to witness the highest growth during the forecast period.”

Based on service, the microbiome sequencing services market is segmented into sample preparation services, sequencing and library preparation services, and data analysis services. Different approaches are employed in microbiome sequencing and library preparation, including 16S rRNA sequencing, shotgun metagenomics, qPCR testing, and short-chain fatty acids (SCFA) analysis. High demand for 16S rRNA sequencing is expected to boost the growth of this segment.

“The sequencing by synthesis (SBS) segment accounted for the largest share of 45% of the global microbiome sequencing services market in 2022.”

Based on technology, the global microbiome sequencing services market is segmented into sequencing by synthesis (SBS), sequencing by ligation (SBL), nanopore sequencing, and other technologies. The SBS technology uses four fluorescently labeled nucleotides to sequence millions of clusters on the flow cell surface in parallel .The SBS technology has a wide customer base owing to its well-established precision in sequencing as well as its broad application base.

“Asia Pacific is estimated to register the highest CAGR during the forecast period.”

The microbiome sequencing services market is segmented into North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa (MEA). The Asia Pacific region is expected to be the fastest-growing market for microbiome sequencing services due to the increasing awareness of the importance of the microbiome in health and disease, rising demand for personalized medicine, and advancements in sequencing technologies.
 
Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Respondent: Supply Side (70%) , Demand side (30%)
• By Designation: Manager-level (45%), CXO and Director-level (35%), and Executives (25%)
• By Region: North America (20%), Europe (10%), AsiaPacific (55%), Latin America(10% ) and Middle EastAfrica(5%)

List of Companies Profiled in the Report
•Charles River Laboratories (US)
•Eurofins Scientific (France)
•BGI (China)
•CosmosID (US)
•Microba (Australia)
•QIAGEN (Germany)
•Microbiome Insights (Canada)
•BaseClear (Netherlands)
•CD Genomics (US)
•Zymo Research (US)
•OraSure Technologies (US)
•MR DNA (US)
•Eremid Genomic Services (US)
•Clinical-Microbiomics A/S (Denmark)
•Novogene Co., Ltd. (China)
•EzBiome (US)
•Boster Biological Technology (US)
•Zifo (India)
•omics2view.consulting GbR (Germany)
•Macrogen, Inc. (South Korea)
 
Research Coverage
This report studies the microbiome sequencing services market based on service, type, technology, end user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total microbiome sequencing services market. The report forecasts the revenue of the market segments with respect to five major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:

•Analysis of key drivers (Increasing demand for metagenomic sequencing, growing focus on human microbiome therapeutics development, and high cost of advanced infrastructure for sequencing), restraints (dearth of skilled personnel), opportunities (Expanding applications of microbiome sequencing in therapeutics development), and challenges (Issues related to sample preparation/isolation of microbes for sequencing) influencing the growth of microbiome sequencing services market.
•Service Development/Innovation: Detailed insights on newly launched services, and technological assessment of the microbiome sequencing services market.
•Market Development: Comprehensive information about lucrative markets – the report analyses the microbiome sequencing services market across varied regions.
•Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the microbiome sequencing services market.
•Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Charles River Laboratories International, Inc. (US), Eurofins Scientific (France), BGI (China) among others in the microbiome sequencing services market. The report also helps stakeholders understand the pulse of microbiome sequencing services market and provides them information on key market drivers, restraints, challenges, and opportunities.

Content
Table of Contents

1INTRODUCTION29
1.1STUDY OBJECTIVES29
1.2MARKET DEFINITION29
1.2.1INCLUSIONS AND EXCLUSIONS30
1.3MARKET SCOPE30
1.3.1MARKETS COVERED30
1.3.2YEARS CONSIDERED31
1.4CURRENCY31
1.5LIMITATIONS31
1.6STAKEHOLDERS32
1.7SUMMARY OF CHANGES32
1.7.1RECESSION IMPACT33
2RESEARCH METHODOLOGY34
2.1RESEARCH DATA34
FIGURE 1RESEARCH DESIGN34
2.1.1SECONDARY DATA35
2.1.2PRIMARY DATA36
FIGURE 2MICROBIOME SEQUENCING SERVICES MARKET: BREAKDOWN OF PRIMARIES36
2.2MARKET ESTIMATION METHODOLOGY37
FIGURE 3MICROBIOME SEQUENCING SERVICES MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 202237
FIGURE 4MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 202238
FIGURE 5ILLUSTRATIVE EXAMPLE OF COMPANY REVENUE ANALYSIS, 202239
2.2.1INSIGHTS FROM PRIMARY EXPERTS40
FIGURE 6MARKET SIZE VALIDATION FROM PRIMARY SOURCES40
2.3MARKET GROWTH RATE PROJECTIONS41
FIGURE 7MICROBIOME SEQUENCING SERVICES MARKET (SUPPLY-SIDE): CAGR PROJECTIONS41
FIGURE 8MICROBIOME SEQUENCING SERVICES MARKET: GROWTH ANALYSIS OF DEMAND-SIDE DRIVERS42
2.4MARKET BREAKDOWN AND DATA TRIANGULATION43
FIGURE 9DATA TRIANGULATION METHODOLOGY43
2.5RESEARCH ASSUMPTIONS44
2.6RISK ANALYSIS44
2.7IMPACT OF RECESSION ON MICROBIOME SEQUENCING SERVICES MARKET44
TABLE 1GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)45
TABLE 2US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)45
TABLE 3US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)45
3EXECUTIVE SUMMARY46
FIGURE 10MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2023 VS. 2028 (USD MILLION)46
FIGURE 11MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)47
FIGURE 12MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)47
FIGURE 13MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)48
FIGURE 14GEOGRAPHICAL SNAPSHOT OF MICROBIOME SEQUENCING SERVICES MARKET49
4PREMIUM INSIGHTS50
4.1MICROBIOME SEQUENCING SERVICES MARKET OVERVIEW50
FIGURE 15GROWING FOCUS ON HUMAN MICROBIOME THERAPEUTICS DEVELOPMENT TO DRIVE MARKET50
4.2NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE AND COUNTRY (2023)51
FIGURE 16SEQUENCING AND LIBRARY PREPARATION SERVICES TO ACCOUNT FOR LARGEST SHARE OF NORTH AMERICAN MICROBIOME SEQUENCING SERVICES MARKET IN 202351
4.3NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)51
FIGURE 17SHOTGUN SEQUENCING SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD51
5MARKET OVERVIEW52
5.1INTRODUCTION52
5.2MARKET DYNAMICS52
FIGURE 18MICROBIOME SEQUENCING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES52
TABLE 4MICROBIOME SEQUENCING SERVICES MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES53
5.2.1DRIVERS53
5.2.1.1Increasing demand for metagenomic sequencing53
5.2.1.2Growing focus on human microbiome therapeutics development54
FIGURE 19ROLE OF MICROBIOME SEQUENCING IN THERAPEUTICS DEVELOPMENT54
5.2.1.3High cost of advanced infrastructure for sequencing55
TABLE 5AVERAGE SELLING PRICE OF NGS SYSTEMS, BY KEY PLAYER (2021)55
5.2.2RESTRAINTS56
5.2.2.1Dearth of skilled personnel56
5.2.3OPPORTUNITIES56
5.2.3.1Expanding applications of microbiome sequencing in therapeutics development56
5.2.4CHALLENGES57
5.2.4.1Issues related to sample preparation/isolation of microbes for sequencing57
5.3TECHNOLOGY ANALYSIS57
5.4TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES59
FIGURE 20REVENUE SHIFT AND NEW REVENUE POCKETS FOR MICROBIOME SEQUENCING SERVICE PROVIDERS59
5.5VALUE CHAIN ANALYSIS60
FIGURE 21VALUE CHAIN ANALYSIS OF MICROBIOME SEQUENCING SERVICES MARKET60
5.6ECOSYSTEM MARKET MAP61
FIGURE 22ECOSYSTEM OF MICROBIOME SEQUENCING SERVICES MARKET61
5.7PORTER’S FIVE FORCES ANALYSIS61
TABLE 6MICROBIOME SEQUENCING SERVICES MARKET: PORTER’S FIVE FORCES ANALYSIS61
5.7.1THREAT OF NEW ENTRANTS61
5.7.2THREAT OF SUBSTITUTES61
5.7.3BARGAINING POWER OF SUPPLIERS61
5.7.4BARGAINING POWER OF BUYERS62
5.7.5INTENSITY OF COMPETITIVE RIVALRY62
5.8REGULATORY ANALYSIS62
5.8.1NORTH AMERICA62
5.8.1.1US62
TABLE 7US FDA: MEDICAL DEVICE CLASSIFICATION63
TABLE 8US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS63
5.8.1.2Canada63
5.8.2EUROPE64
5.8.3ASIA PACIFIC65
5.8.3.1China65
TABLE 9CHINA: CLASSIFICATION OF MEDICAL DEVICES65
5.8.3.2Japan65
5.8.3.3India66
5.8.4LATIN AMERICA66
5.8.5MIDDLE EAST66
5.8.6REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS67
TABLE 10REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS: GENOMICS, MICROBIOME RESEARCH, AND METAGENOMICS67
5.9PRICING ANALYSIS68
TABLE 11AVERAGE SELLING PRICE, BY SERVICE AND TYPE68
5.9.1AVERAGE SELLING PRICE TREND ANALYSIS69
5.10KEY CONFERENCES AND EVENTS IN 2023–202470
TABLE 12MICROBIOME SEQUENCING/METAGENOMIC SEQUENCING/NGS CONFERENCES, 2023–202470
5.11KEY STAKEHOLDERS AND BUYING CRITERIA72
FIGURE 23INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SEQUENCING SERVICES72
FIGURE 24CRITERIA FOR OUTSOURCING SEQUENCING SERVICES72
6MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE73
6.1INTRODUCTION74
TABLE 13MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION)74
6.2SAMPLE PREPARATION74
6.2.1NEED FOR SPECIFIC SAMPLE PREPARATION PROTOCOLS BASED ON SAMPLE TYPE TO DRIVE GROWTH74
TABLE 14MICROBIOME SEQUENCING SERVICES MARKET FOR SAMPLE PREPARATION, BY REGION, 2021–2028 (USD MILLION)75
TABLE 15NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)75
TABLE 16EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)75
TABLE 17ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)76
TABLE 18LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)76
6.3SEQUENCING AND LIBRARY PREPARATION76
6.3.1SEQUENCING AND LIBRARY PREPARATION SERVICES TO DOMINATE MARKET DURING FORECAST PERIOD76
TABLE 19MICROBIOME SEQUENCING SERVICES MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY REGION, 2021–2028 (USD MILLION)77
TABLE 20NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)77
TABLE 21EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)77
TABLE 22ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)78
TABLE 23LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)78
6.4DATA ANALYSIS78
6.4.1DEVELOPMENT OF ADVANCED BIOINFORMATICS SOLUTIONS TO DRIVE GROWTH78
TABLE 24MICROBIOME SEQUENCING SERVICES MARKET FOR DATA ANALYSIS, BY REGION, 2021–2028 (USD MILLION)79
TABLE 25NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION)79
TABLE 26EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION)79
TABLE 27ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION)80
TABLE 28LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION)80
7MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE81
7.1INTRODUCTION82
TABLE 29MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)82
7.2AMPLICON SEQUENCING82
7.2.1HIGH ACCURACY OF 16S AMPLICON SEQUENCING TO DRIVE ADOPTION82
TABLE 30AMPLICON SEQUENCING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)83
TABLE 31NORTH AMERICA: AMPLICON SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)83
TABLE 32EUROPE: AMPLICON SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)83
TABLE 33ASIA PACIFIC: AMPLICON SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)84
TABLE 34LATIN AMERICA: AMPLICON SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)84
7.3WHOLE-GENOME SEQUENCING84
7.3.1ACCURATE REFERENCE GENOMES GENERATED FOR MICROBIAL IDENTIFICATION TO BOOST MARKET84
TABLE 35WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)85
TABLE 36NORTH AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)85
TABLE 37EUROPE: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)85
TABLE 38ASIA PACIFIC: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)86
TABLE 39LATIN AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)86
7.4SHOTGUN SEQUENCING86
7.4.1ADVANCEMENTS IN DATA ANALYSIS SOLUTIONS TO SUPPORT ADOPTION86
TABLE 40SHOTGUN SEQUENCING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)87
TABLE 41NORTH AMERICA: SHOTGUN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)87
TABLE 42EUROPE: SHOTGUN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)88
TABLE 43ASIA PACIFIC: SHOTGUN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)88
TABLE 44LATIN AMERICA: SHOTGUN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)88
7.5OTHER TYPES89
TABLE 45OTHER MICROBIOME SEQUENCING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)89
TABLE 46NORTH AMERICA: OTHER MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)89
TABLE 47EUROPE: OTHER MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)90
TABLE 48ASIA PACIFIC: OTHER MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)90
TABLE 49LATIN AMERICA: OTHER MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)90
8MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY91
8.1INTRODUCTION92
TABLE 50MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)92
8.2SEQUENCING BY SYNTHESIS (SBS)92
8.2.1SBS TECHNOLOGY ENABLES HIGHEST PRODUCTION OF BASE PAIRS IN SHORT TIME92
TABLE 51MICROBIOME SEQUENCING SERVICES MARKET FOR SBS, BY REGION, 2021–2028 (USD MILLION)93
TABLE 52NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SBS, BY COUNTRY, 2021–2028 (USD MILLION)93
TABLE 53EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR SBS, BY COUNTRY, 2021–2028 (USD MILLION)93
TABLE 54ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR SBS, BY COUNTRY, 2021–2028 (USD MILLION)94
TABLE 55LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SBS, BY COUNTRY, 2021–2028 (USD MILLION)94
8.3SEQUENCING BY LIGATION (SBL)94
8.3.1INCREASING DEMAND FOR SBL IN FOOD MICROBIOME RESEARCH TO BOOST GROWTH94
TABLE 56MICROBIOME SEQUENCING SERVICES MARKET FOR SBL, BY REGION, 2021–2028 (USD MILLION)95
TABLE 57NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SBL, BY COUNTRY, 2021–2028 (USD MILLION)95
TABLE 58EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR SBL, BY COUNTRY, 2021–2028 (USD MILLION)95
TABLE 59ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR SBL, BY COUNTRY, 2021–2028 (USD MILLION)96
TABLE 60LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SBL, BY COUNTRY, 2021–2028 (USD MILLION)96
8.4NANOPORE SEQUENCING96
8.4.1ONLY SEQUENCING TECHNOLOGY WITH DIRECT RNA SEQUENCING CAPABILITIES96
TABLE 61MICROBIOME SEQUENCING SERVICES MARKET FOR NANOPORE SEQUENCING, BY REGION, 2021–2028 (USD MILLION)97
TABLE 62NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2021–2028 (USD MILLION)97
TABLE 63EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2021–2028 (USD MILLION)98
TABLE 64ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2021–2028 (USD MILLION)98
TABLE 65LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2021–2028 (USD MILLION)98
8.5OTHER TECHNOLOGIES99
TABLE 66MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021–2028 (USD MILLION)99
TABLE 67NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)99
TABLE 68EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)100
TABLE 69ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)100
TABLE 70LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)100
9MICROBIOME SEQUENCING SERVICES MARKET, BY END USER101
9.1INTRODUCTION102
TABLE 71MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)102
9.2PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES102
9.2.1ROBUST FUNDING FOR MICROBIOME-BASED THERAPEUTICS TO DRIVE MARKET102
TABLE 72MICROBIOME SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)103
TABLE 73NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)103
TABLE 74EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)104
TABLE 75ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)104
TABLE 76LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)104
9.3ACADEMIC AND RESEARCH INSTITUTES105
9.3.1EXPANDING APPLICATIONS OF MICROBIOME RESEARCH TO DRIVE GROWTH105
TABLE 77MICROBIOME SEQUENCING SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)105
TABLE 78NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)106
TABLE 79EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)106
TABLE 80ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)106
TABLE 81LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)107
9.4OTHER END USERS107
TABLE 82MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)108
TABLE 83NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)108
TABLE 84EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)108
TABLE 85ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)109
TABLE 86LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)109
10MICROBIOME SEQUENCING SERVICES MARKET, BY REGION110
10.1INTRODUCTION111
FIGURE 25MICROBIOME SEQUENCING SERVICES MARKET, BY REGION, 2023 VS. 2028 (USD MILLION)111
TABLE 87MICROBIOME SEQUENCING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)112
10.2NORTH AMERICA112
FIGURE 26NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET SNAPSHOT113
TABLE 88NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)114
TABLE 89NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION)114
TABLE 90NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)114
TABLE 91NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)115
TABLE 92NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)115
10.2.1US115
10.2.1.1Increasing awareness of microbiome research to drive growth115
TABLE 93US: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION)116
TABLE 94US: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)116
TABLE 95US: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)117
TABLE 96US: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)117
10.2.2CANADA117
10.2.2.1Increasing prevalence of chronic diseases to boost microbiome research117
TABLE 97CANADA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION)118
TABLE 98CANADA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)118
TABLE 99CANADA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)119
TABLE 100CANADA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)119
10.2.3NORTH AMERICA: IMPACT OF RECESSION119
10.3EUROPE120
TABLE 101EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)121
TABLE 102EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION)121
TABLE 103EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)121
TABLE 104EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)122
TABLE 105EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)122
10.3.1GERMANY122
10.3.1.1Rapidly increasing government funding to support growth122
TABLE 106GERMANY: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION)123
TABLE 107GERMANY: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)123
TABLE 108GERMANY: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)124
TABLE 109GERMANY: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)124
10.3.2UK124
10.3.2.1Significant government investments in genomics research to propel growth124
TABLE 110UK: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION)125
TABLE 111UK: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)125
TABLE 112UK: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)126
TABLE 113UK: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)126
10.3.3FRANCE126
10.3.3.1Growing number of microbiome sequencing startups to propel growth126
TABLE 114HUMAN MICROBIOME STARTUPS IN FRANCE127
TABLE 115FRANCE: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION)127
TABLE 116FRANCE: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)128
TABLE 117FRANCE: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)128
TABLE 118FRANCE: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)128
10.3.4ITALY129
10.3.4.1Increasing use of microbiome services in clinical research to drive growth129
TABLE 119ITALY: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION)129
TABLE 120ITALY: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)130
TABLE 121ITALY: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)130
TABLE 122ITALY: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)130
10.3.5SPAIN131
10.3.5.1Increasing prevalence of chronic diseases to drive market131
TABLE 123SPAIN: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION)131
TABLE 124SPAIN: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)131
TABLE 125SPAIN: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)132
TABLE 126SPAIN: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)132
10.3.6REST OF EUROPE132
TABLE 127REST OF EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION)133
TABLE 128REST OF EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)133
TABLE 129REST OF EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)133
TABLE 130REST OF EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)134
10.3.7EUROPE: IMPACT OF RECESSION134
10.4ASIA PACIFIC135
FIGURE 27ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET SNAPSHOT136
TABLE 131ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)137
TABLE 132ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION)137
TABLE 133ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)137
TABLE 134ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)138
TABLE 135ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)138
 
10.4.1CHINA138
10.4.1.1Increasing investments in R&D to drive growth138
TABLE 136CHINA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION)139
TABLE 137CHINA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)139
TABLE 138CHINA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)140
TABLE 139CHINA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)140
10.4.2JAPAN140
10.4.2.1Significant growth in geriatric population to present opportunities for market growth140
TABLE 140JAPAN: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION)141
TABLE 141JAPAN: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)141
TABLE 142JAPAN: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)142
TABLE 143JAPAN: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)142
10.4.3INDIA142
10.4.3.1Increasing prevalence of chronic diseases to support growth142
TABLE 144INDIA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION)143
TABLE 145INDIA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)143
TABLE 146INDIA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)144
TABLE 147INDIA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)144
10.4.4REST OF ASIA PACIFIC144
TABLE 148REST OF ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION)145
TABLE 149REST OF ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)145
TABLE 150REST OF ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)145
TABLE 151REST OF ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)146
10.4.5ASIA PACIFIC: IMPACT OF RECESSION146
10.5LATIN AMERICA146
TABLE 152LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)147
TABLE 153LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION)147
TABLE 154LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)147
TABLE 155LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)148
TABLE 156LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)148
10.5.1BRAZIL149
10.5.1.1Growing adoption of next-generation sequencing technologies to propel growth149
TABLE 157BRAZIL: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION)149
TABLE 158BRAZIL: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)149
TABLE 159BRAZIL: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)150
TABLE 160BRAZIL: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)150
10.5.2REST OF LATIN AMERICA150
TABLE 161REST OF LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION)151
TABLE 162REST OF LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)151
TABLE 163REST OF LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)151
TABLE 164REST OF LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)152
10.5.3LATIN AMERICA: IMPACT OF RECESSION152
10.6MIDDLE EAST & AFRICA153
TABLE 165MIDDLE EAST & AFRICA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION)153
TABLE 166MIDDLE EAST & AFRICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)153
TABLE 167MIDDLE EAST & AFRICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)154
TABLE 168MIDDLE EAST & AFRICA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)154
10.6.1MIDDLE EAST & AFRICA: IMPACT OF RECESSION154
11COMPETITIVE LANDSCAPE155
11.1OVERVIEW155
11.2STRATEGIES ADOPTED BY KEY PLAYERS156
FIGURE 28STRATEGIES ADOPTED BY KEY PLAYERS IN MICROBIOME SEQUENCING SERVICES MARKET, 2020–2023156
11.3MARKET SHARE ANALYSIS157
FIGURE 29MICROBIOME SEQUENCING SERVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022157
TABLE 169MICROBIOME SEQUENCING SERVICES MARKET: DEGREE OF COMPETITION157
11.4REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS158
FIGURE 30REVENUE SHARE ANALYSIS OF TOP PLAYERS IN MICROBIOME SEQUENCING SERVICES MARKET, 2020–2022158
11.5COMPANY EVALUATION QUADRANT159
11.5.1STARS159
11.5.2EMERGING LEADERS159
11.5.3PERVASIVE PLAYERS159
11.5.4PARTICIPANTS159
FIGURE 31MICROBIOME SEQUENCING SERVICES MARKET: COMPANY EVALUATION QUADRANT, 2022160
11.6COMPETITIVE SCENARIO161
TABLE 170SERVICE LAUNCHES161
TABLE 171DEALS161
12COMPANY PROFILES163
12.1KEY PLAYERS163
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.1.1CHARLES RIVER LABORATORIES163
TABLE 172CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW163
FIGURE 32CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022)164
12.1.2EUROFINS SCIENTIFIC166
TABLE 173EUROFINS SCIENTIFIC: BUSINESS OVERVIEW166
FIGURE 33EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2022)166
12.1.3BGI GROUP168
TABLE 174BGI GROUP: BUSINESS OVERVIEW168
12.1.4COSMOSID169
TABLE 175COSMOSID: BUSINESS OVERVIEW169
12.1.5MICROBA171
TABLE 176MICROBA: BUSINESS OVERVIEW171
12.1.6QIAGEN N.V.173
TABLE 177QIAGEN N.V.: BUSINESS OVERVIEW173
FIGURE 34QIAGEN N.V.: COMPANY SNAPSHOT (2022)174
12.1.7MICROBIOME INSIGHTS176
TABLE 178MICROBIOME INSIGHTS: BUSINESS OVERVIEW176
12.1.8BASECLEAR178
TABLE 179BASECLEAR: BUSINESS OVERVIEW178
12.1.9CD GENOMICS179
TABLE 180CD GENOMICS: COMPANY OVERVIEW179
12.1.10ZYMO RESEARCH CORPORATION181
TABLE 181ZYMO RESEARCH CORPORATION: COMPANY OVERVIEW181
12.1.11ORASURE TECHNOLOGIES183
TABLE 182ORASURE TECHNOLOGIES: BUSINESS OVERVIEW183
FIGURE 35ORASURE TECHNOLOGIES: COMPANY SNAPSHOT (2022)184
12.1.12MR DNA186
TABLE 183MR DNA: BUSINESS OVERVIEW186
12.1.13EREMID GENOMIC SERVICES187
TABLE 184EREMID GENOMIC SERVICES: BUSINESS OVERVIEW187
12.1.14CLINICAL-MICROBIOMICS A/S188
TABLE 185CLINICAL-MICROBIOMICS A/S: BUSINESS OVERVIEW188
12.1.15NOVOGENE CO., LTD.190
TABLE 186NOVOGENE CO., LTD.: BUSINESS OVERVIEW190
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
12.2OTHER PLAYERS191
12.2.1EZBIOME191
12.2.2BOSTER BIOLOGICAL TECHNOLOGY191
12.2.3ZIFO192
12.2.4OMICS2VIEW.CONSULTING GBR192
12.2.5MACROGEN, INC.193
13APPENDIX194
13.1DISCUSSION GUIDE194
13.2KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL197
13.3CUSTOMIZATION OPTIONS199
13.4RELATED REPORTS199
13.5AUTHOR DETAILS200